Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michelle Mellion, MD
Fulcrum Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
- Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada
- Chu de Nice- Chu Pasteur2
Nice, France
- Hospital de la Sta Creu I St Pau
Barcelona, Spain
- Hospital Uip la Fe
Valencia, Spain
- University of California Irvine
Irvine, California, United States
- University of California Los Angeles (ucla)
Los Angeles, California, United States
- University of Florida
Gainesville, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Kennedy Krieger Institute
Baltimore, Maryland, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Ohio State University
Columbus, Ohio, United States
- University of Utah
Salt Lake City, Utah, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- University of Washinton Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2019
- Primary completion
- 28 Jan 2021
- Completion
- 28 Jan 2021
- Last update posted
- 10 Jul 2024
- Registered enrollment
- 80
- Registry id
- NCT04003974
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.